Thomas Gossios

2.2k total citations · 1 hit paper
56 papers, 1.3k citations indexed

About

Thomas Gossios is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Thomas Gossios has authored 56 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cardiology and Cardiovascular Medicine, 12 papers in Surgery and 10 papers in Molecular Biology. Recurrent topics in Thomas Gossios's work include Cardiomyopathy and Myosin Studies (21 papers), Cardiovascular Effects of Exercise (13 papers) and Cardiovascular Function and Risk Factors (11 papers). Thomas Gossios is often cited by papers focused on Cardiomyopathy and Myosin Studies (21 papers), Cardiovascular Effects of Exercise (13 papers) and Cardiovascular Function and Risk Factors (11 papers). Thomas Gossios collaborates with scholars based in Greece, United Kingdom and United States. Thomas Gossios's co-authors include Vasilios G. Athyros, Asterios Karagiannis, Κωνσταντίνος Τζιόμαλος, Eleni Theocharidou, Efstathios D. Pagourelias, Dimitri P. Mikhailidis, Theodora Griva, Panagiotis Anagnostis, Konstantinos Kargiotis and Georgios Efthimiadis and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Thomas Gossios

47 papers receiving 1.2k citations

Hit Papers

Safety and efficacy of long-term statin treatment for car... 2010 2026 2015 2020 2010 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Gossios Greece 18 594 480 318 282 146 56 1.3k
Baihui Xu China 19 241 0.4× 378 0.8× 174 0.5× 366 1.3× 88 0.6× 31 985
L. Bertolini Italy 11 275 0.5× 784 1.6× 204 0.6× 521 1.8× 224 1.5× 14 1.1k
Tracey E. Toms United Kingdom 23 381 0.6× 134 0.3× 180 0.6× 59 0.2× 151 1.0× 33 1.5k
Chia‐Chang Hsu Taiwan 17 154 0.3× 334 0.7× 160 0.5× 68 0.2× 166 1.1× 50 921
Seiichiro Kojima Japan 14 356 0.6× 576 1.2× 373 1.2× 211 0.7× 432 3.0× 56 1.2k
G Pagano Italy 13 170 0.3× 643 1.3× 238 0.7× 614 2.2× 112 0.8× 35 1.2k
Anthony L. Pucillo United States 15 910 1.5× 290 0.6× 505 1.6× 214 0.8× 36 0.2× 53 1.7k
Ender Örnek Türkiye 19 498 0.8× 300 0.6× 303 1.0× 209 0.7× 12 0.1× 78 1.3k
Hideaki Jinnouchi Japan 15 722 1.2× 130 0.3× 372 1.2× 191 0.7× 24 0.2× 40 1.3k
B. Bottasso Italy 21 283 0.5× 108 0.2× 216 0.7× 151 0.5× 51 0.3× 38 1.5k

Countries citing papers authored by Thomas Gossios

Since Specialization
Citations

This map shows the geographic impact of Thomas Gossios's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Gossios with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Gossios more than expected).

Fields of papers citing papers by Thomas Gossios

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Gossios. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Gossios. The network helps show where Thomas Gossios may publish in the future.

Co-authorship network of co-authors of Thomas Gossios

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Gossios. A scholar is included among the top collaborators of Thomas Gossios based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Gossios. Thomas Gossios is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Theocharidou, Eleni & Thomas Gossios. (2025). Effect of Statins and PCSK9 Inhibition on Metabolic Dysfunction–Associated Steatotic Liver Disease. Journal of Digestive Diseases. 26(9-10). 392–397.
3.
Zegkos, Thomas, Despοina Parcharidou, Thomas Gossios, et al.. (2025). Transthyretin Amyloid Cardiomyopathy: Current Diagnostic Approach and Risk Stratification with Multimodality Imaging. Journal of Clinical Medicine. 14(6). 2014–2014. 1 indexed citations
4.
Domínguez, Martín Ortiz, Fernándo Domínguez, Pablo García‐Pavía, et al.. (2024). Pathogenic truncating filamin C mutations presenting as acute myocarditis: a case series with insights from cardiac magnetic resonance and histological analysis. European Heart Journal - Case Reports. 8(3). ytae111–ytae111. 3 indexed citations
5.
Anastasiou, Vasileios, Αndreas S. Papazoglou, Thomas Gossios, et al.. (2024). Prognostic Implications of Genotype Findings in Non-Ischaemic Dilated Cardiomyopathy: A Network Meta-Analysis. European Journal of Heart Failure. 26(10). 2155–2168. 1 indexed citations
6.
Anastasiou, Vasileios, Αndreas S. Papazoglou, Dimitrios V. Moysidis, et al.. (2023). The prognostic impact of right ventricular-pulmonary arterial coupling in heart failure: a systematic review and meta-analysis. Heart Failure Reviews. 29(1). 13–26. 23 indexed citations
7.
Pitsis, Antoniοs, Thomas Zegkos, Theodora Papamitsou, et al.. (2023). Periostin is overexpressed, correlated with fibrosis and differs among grades of cardiomyocyte hypertrophy in myectomy tissue of patients with hypertrophic cardiomyopathy. PLoS ONE. 18(11). e0293427–e0293427. 2 indexed citations
8.
Gossios, Thomas, et al.. (2021). Risk Prediction Models and Scores in Hypertrophic Cardiomyopathy. Current Pharmaceutical Design. 27(10). 1254–1265. 1 indexed citations
9.
Gossios, Thomas, Konstantinos Savvatis, Thomas Zegkos, et al.. (2021). Deciphering hypertrophic cardiomyopathy with electrocardiography. Heart Failure Reviews. 27(4). 1313–1323. 3 indexed citations
10.
Zegkos, Thomas, Despοina Parcharidou, Christos A. Papanastasiou, et al.. (2021). Validation of the new American College of Cardiology/American Heart Association Guidelines for the risk stratification of sudden cardiac death in a large Mediterranean cohort with Hypertrophic Cardiomyopathy. Hellenic Journal of Cardiology. 63. 15–21. 20 indexed citations
11.
Protonotarios, Alexandros, Andreas Brodehl, Angeliki Asimaki, et al.. (2020). The Novel Desmin Variant p.Leu115Ile Is Associated With a Unique Form of Biventricular Arrhythmogenic Cardiomyopathy. Canadian Journal of Cardiology. 37(6). 857–866. 28 indexed citations
12.
Theocharidou, Eleni, Όλγα Γιουλεμέ, Efstathios D. Pagourelias, et al.. (2019). Free Cortisol Is a More Accurate Marker for Adrenal Function and Does Not Correlate with Renal Function in Cirrhosis. Digestive Diseases and Sciences. 64(6). 1686–1694. 6 indexed citations
13.
Ziakas, Antonios, Michael Koutouzis, Matthaios Didagelos, et al.. (2018). Right arm distal transradial (snuffbox) access for coronary catheterization: Initial experience. Hellenic Journal of Cardiology. 61(2). 106–109. 38 indexed citations
14.
Theocharidou, Eleni, Konstantinos Vogiatzis, Constantinos C. Tellis, et al.. (2016). Hypertrophic Mesenteric Adipose Tissue May Play a Role in Atherogenesis in Inflammatory Bowel Diseases. Inflammatory Bowel Diseases. 22(9). 2206–2212. 9 indexed citations
15.
Theocharidou, Eleni, Constantinos C. Tellis, Konstantinos Soufleris, et al.. (2014). Lipoprotein-associated phospholipase A2 and arterial stiffness evaluation in patients with inflammatory bowel diseases. Journal of Crohn s and Colitis. 8(9). 936–944. 19 indexed citations
16.
Athyros, Vasilios G., Κωνσταντίνος Τζιόμαλος, Niki Katsiki, et al.. (2013). The Impact of Smoking on Cardiovascular Outcomes and Comorbidities in Statin-treated Patients with Coronary Artery Disease: A Post hoc Analysis of the GREACE Study. Current Vascular Pharmacology. 11(5). 779–784. 14 indexed citations
17.
Gossios, Thomas, Luís R. Lopes, & Perry Elliott. (2013). Left ventricular hypertrophy caused by a novel nonsense mutation in FHL1. European Journal of Medical Genetics. 56(5). 251–255. 17 indexed citations
18.
Koumaras, Charalambos, Theodora Griva, Thomas Gossios, et al.. (2012). Role of Antihypertensive Drugs in Arterial ‘De-Stiffening’ and Central Pulsatile Hemodynamics. American Journal of Cardiovascular Drugs. 12(3). 143–156. 40 indexed citations
19.
Athyros, Vasilios G., Apostolos Hatzitolios, Asterios Karagiannis, et al.. (2011). IMproving the imPlemEntation of cuRrent guidelines for the mAnagement of major coronary hearT disease rIsk factors by multifactorial interVEntion. The IMPERATIVE renal analysis. Archives of Medical Science. 6(6). 984–992. 36 indexed citations
20.
Efthimiadis, Georgios, et al.. (2011). Prognostic value of right ventricular diastolic function indices in hypertrophic cardiomyopathy. European Journal of Echocardiography. 12(11). 809–817. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026